« Back
Comparison of Smoker’s and Non-Smoker’s Urine Using Comprehensive Two-Dimensional Gas Chromatography High Performance Time-of-Flight Mass Spectrometry
Poster Title: Comparison of Smoker’s and Non-Smoker’s Urine Using Comprehensive Two-Dimensional Gas Chromatography High Performance Time-of-Flight Mass Spectrometry
Submitted on 07 Mar 2018
Author(s): David E. Alonso and Joseph E. Binkley
Affiliations: LECO Corporation
This poster was presented at Pittcon 2018
Poster Views: 652
View poster »

Poster Information
Abstract: Urine is a favored biofluid for diagnostic testing (Urinalysis) because it is non-invasive and large volumes are easily obtained. In addition, urine is relatively free from interfering proteins and lipids, and it tends to “hold” high concentrations of drugs and metabolites over extended periods of time. Modern, routine clinical tests include the determination of specific gravity, measurement of glucose, nitrates, etc.

In this study, a novel analytical approach was utilized for the effective characterization of compounds in two standard reference materials, NIST smoker’s and non-smoker’s urine.

Implement the use of enhanced, comprehensive two-dimensional gas chromatography (GCxGC) for the separation of compounds in urine
Use a benchtop, high-performance time-of-flight mass spectrometer and powerful processing software to quickly and confidently identify compounds in urine
Use software tools to compare smoker’s and non-smoker’s urine
Summary: The Pegasus BT 4D facilitates fast and confident compound identification through enhanced two-dimensional chromatographic resolution and high performance TOFMS.
Robust compound identification was obtained through spectral similarity searches of large, well-established databases, mass D calculations and retention index filtering.
Comprehensive data can be processed via non-targeted Peak Find or rapid Target Analyte Finding.
Report abuse »
Ask the author a question about this poster.
Ask a Question »

Creative Commons

Related Posters

Combining Imaging and OMICs: MALDI guided SpatialOMx probes proteomic mass profiles of breast cancer tumor subpopulations
Janina Oetjen 1 , Romano Hebeler 1 , Frédéric Dewez 2 , Corinna Henkel 1 , Benjamin Balluff 2 , Ron Heeren 2

Novel MALDI-TOF MS Workflow for Ultrahigh-Throughput Screening of Different Analytes at Each Position on a Plate
Sergei Dikler

Coloración simultánea alcian blue pH 2.5/cytokeratin(AE1&AE3) en carcinoma gástrico con células en anillo de sello
Lic. T.M. López Mendieta Juan Sebastián; Lic. T.M. Romero Mariño,Rosa Luz; Lic. T.M. Peña Torres ,Iván Franco

Evaluation of Laser Cleaning of Parchment, Wool and Featherwith High Performance Liquid Chromatography and AttenuatedTotal Reflection -Fourier Transform Infrared Spectroscopy
Stamatis C. Boyatzis, Eleni Ioakimoglou, Eleni Tziamourani, Efrosini Karantoni Ekaterini Malea, Stavroula Rapti, Paraskevi Pouli, Athanassia Papanikolaou, Kristalia Melessanaki, Georgios Panagiaris

FXa Anticoagulant Bioactive Proteins Derived from Scorpion Venom
Meng Li,1 Yuko P. Y. Lam,1 Peng Chen,2 Remy Gavard,1 Cookson K. C. Chiu,1 Christopher A. Wootton,1 Tomos E. Morgan,1 Qiong Wu,2 Mark P. Barrow,1 Hongzheng Fu,2 Peter B. O’Connor1